Clinical trial
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV)…
NCT00328549 · Ortho Biotech Products, L.P., Industry · Completed
Key facts
| NCT number | NCT00328549 |
|---|---|
| Title | A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) |
| Official title | A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C, Anemia |
| Intervention type | Drug |
| Interventions | Pegylated Interferon and Ribavirin |
| Enrollment | 105 |
| Start date | Oct 1, 2001 |
| Completion | Dec 1, 2002 |
| First posted | May 22, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: